Marc Wilson

Insider Reports History

Location
San Diego, CA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc Wilson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. CFO Common Stock 111,565 $1,671,244 $14.98 20 Nov 2024 Direct
Crinetics Pharmaceuticals, Inc. CFO Stock option (Right to Buy) 89,000 26 Sep 2024 Direct

Insider Reports Filed by Marc Wilson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 31 Dec 2024 1 +$7,086 5 CFO 29 Jan 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 26 Sep 2024 3 -$895,500 4 CFO 30 Sep 2024, 17:01
CRNX Crinetics Pharmaceuticals, Inc. 25 Jul 2024 3 -$849,898 4 CFO 26 Jul 2024, 16:24
CRNX Crinetics Pharmaceuticals, Inc. 15 Jul 2024 3 -$874,500 4 CFO 17 Jul 2024, 17:14
CRNX Crinetics Pharmaceuticals, Inc. 28 Jun 2024 3 -$1,102,989 4 CFO 02 Jul 2024, 16:32
CRNX Crinetics Pharmaceuticals, Inc. 18 Mar 2024 2 -$449,793 4 CFO 20 Mar 2024, 18:32
CRNX Crinetics Pharmaceuticals, Inc. 04 Mar 2024 2 $0 4 CFO 06 Mar 2024, 20:01
CRNX Crinetics Pharmaceuticals, Inc. 02 Jan 2024 3 -$261,900 4 CFO 04 Jan 2024, 16:43
CRNX Crinetics Pharmaceuticals, Inc. 01 Nov 2023 3 -$194,700 4 CFO 03 Nov 2023, 19:38
CRNX Crinetics Pharmaceuticals, Inc. 20 Jun 2023 4 -$431,803 4 CFO 21 Jun 2023, 17:32
CRNX Crinetics Pharmaceuticals, Inc. 16 Mar 2023 1 -$28,522 4 CFO 17 Mar 2023, 17:11
CRNX Crinetics Pharmaceuticals, Inc. 01 Mar 2023 2 $0 4 CFO 03 Mar 2023, 15:33
CRNX Crinetics Pharmaceuticals, Inc. 31 Dec 2022 2 +$21,247 5 CFO 27 Jan 2023, 15:29
CRNX Crinetics Pharmaceuticals, Inc. 28 Feb 2022 2 $0 4 CFO 02 Mar 2022, 20:00
CRNX Crinetics Pharmaceuticals, Inc. 31 Dec 2021 2 +$21,236 5 CFO 04 Feb 2022, 15:30